Der bundeseinheitliche Medikationsplan in der Praxis [Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA].

Dormann, H; Maas, R; Eickhoff, C; Müller, U; Schulz, M; Brell, D; Thürmann, PA; MetropolMediplan 2016,; Modellregion Erfurt,; PRIMA,

Der bundeseinheitliche Medikationsplan in der Praxis [Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA].

Dormann, H Maas, R Eickhoff, C Müller, U Schulz, M

Brell, D Thürmann, PA MetropolMediplan 2016, Modellregion Erfurt, PRIMA,

Permalink

Publisher:: Springer
Publication Type:: Journal Article
Citation:: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2018, 61, (9), pp. 1093-1102
Issue Date:: 2018-09

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (470.21 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Dormann, H
dc.contributor.author	Maas, R
dc.contributor.author	Eickhoff, C
dc.contributor.author	Müller, U
dc.contributor.author	Schulz, M https://orcid.org/0000-0002-5876-7322
dc.contributor.author	Brell, D
dc.contributor.author	Thürmann, PA
dc.contributor.author	MetropolMediplan 2016,
dc.contributor.author	Modellregion Erfurt,
dc.contributor.author	PRIMA,
dc.date.accessioned	2022-09-11T20:09:17Z
dc.date.available	2022-09-11T20:09:17Z
dc.date.issued	2018-09
dc.identifier.citation	Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2018, 61, (9), pp. 1093-1102
dc.identifier.issn	1437-1588
dc.identifier.issn	1437-1588
dc.identifier.uri	http://hdl.handle.net/10453/161665
dc.description.abstract	Since 1 October 2016, all legally insured persons are entitled to a nationwide medication plan (BMP) under certain conditions (according to § 31a SGB V, E-Health Law). The catalogue of measures of the 3rd Action Plan 2013-2015 for the improvement of drug therapy safety (AMTS) provided for the testing of a medication plan in practice, including its acceptance and practicability in three model projects. These three projects - MetropolMediplan 2016, Erfurt, and PRIMA - are presented and recommendations are derived on the basis of the collected findings. Overall, the BMP was welcomed by the participating patients in all projects and led to an increase in satisfaction and an improvement in competence with regard to medication. Both doctors and pharmacists rated the interdisciplinary cooperation via the medium BMP very positively. The high effort and lack of technical infrastructure without electronic availability of the last current version of a BMP of the individual patient was perceived as negative. An original data comparison of the BMP data with the drugs actually taken in the MetropolMediplan 2016 project showed that only 36% of the patients were in agreement with the BMP and the drugs presently taken. The paper version of the BMP has therefore not yet been able to solve the problem of the timeliness and completeness of the medication. In addition to various proposals for the further development of BMP, all parties involved require the BMP to be available electronically across all sectors. The BMP should therefore be an important instrument for improving AMTS in the future.
dc.format	Print
dc.language	ger
dc.publisher	Springer
dc.relation.ispartof	Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
dc.relation.isbasedon	10.1007/s00103-018-2789-9
dc.rights	info:eu-repo/semantics/openAccess
dc.subject.classification	Environmental & Occupational Health
dc.subject.mesh	Germany
dc.subject.mesh	Humans
dc.subject.mesh	Pharmacists
dc.subject.mesh	Physicians
dc.subject.mesh	Pilot Projects
dc.subject.mesh	State Medicine
dc.subject.mesh	Germany
dc.subject.mesh	Humans
dc.subject.mesh	Pharmacists
dc.subject.mesh	Physicians
dc.subject.mesh	Pilot Projects
dc.subject.mesh	State Medicine
dc.subject.mesh	Humans
dc.subject.mesh	Pilot Projects
dc.subject.mesh	Pharmacists
dc.subject.mesh	Physicians
dc.subject.mesh	State Medicine
dc.subject.mesh	Germany
dc.title	Der bundeseinheitliche Medikationsplan in der Praxis [Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA].
dc.type	Journal Article
utslib.citation.volume	61
utslib.location.activity	Germany
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
pubs.consider-herdc	false
dc.date.updated	2022-09-11T20:09:15Z
pubs.issue	9
pubs.publication-status	Published
pubs.volume	61
utslib.citation.issue	9

Abstract:

Since 1 October 2016, all legally insured persons are entitled to a nationwide medication plan (BMP) under certain conditions (according to § 31a SGB V, E-Health Law). The catalogue of measures of the 3rd Action Plan 2013-2015 for the improvement of drug therapy safety (AMTS) provided for the testing of a medication plan in practice, including its acceptance and practicability in three model projects. These three projects - MetropolMediplan 2016, Erfurt, and PRIMA - are presented and recommendations are derived on the basis of the collected findings. Overall, the BMP was welcomed by the participating patients in all projects and led to an increase in satisfaction and an improvement in competence with regard to medication. Both doctors and pharmacists rated the interdisciplinary cooperation via the medium BMP very positively. The high effort and lack of technical infrastructure without electronic availability of the last current version of a BMP of the individual patient was perceived as negative. An original data comparison of the BMP data with the drugs actually taken in the MetropolMediplan 2016 project showed that only 36% of the patients were in agreement with the BMP and the drugs presently taken. The paper version of the BMP has therefore not yet been able to solve the problem of the timeliness and completeness of the medication. In addition to various proposals for the further development of BMP, all parties involved require the BMP to be available electronically across all sectors. The BMP should therefore be an important instrument for improving AMTS in the future.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/161665